BlueStar® Genomic Health Care Index
The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
Country and Sector Weightings
MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.
| Country | Components | Weight |
| United States | 64 | 84.41% |
| Belgium | 1 | 0.99% |
| Germany | 3 | 2.78% |
| Netherlands | 1 | 1.32% |
| United Kingdom | 5 | 5.24% |
| Japan | 2 | 1.97% |
| New Zealand | 1 | 0.35% |
| China | 2 | 2.94% |
| Total | 79 | 100.00% |
| Sector | Components | Weight |
| Materials | 1 | 1.11% |
| Health Care | 78 | 98.89% |
| Total | 79 | 100.00% |
Size Weightings
- Large-Cap: companies with a market capitalisation above 6,000 mln
USD
- Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln
USD
- Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln
USD
- Micro-Cap: companies with a market capitalisation up to 200 mln
USD
| Size | Market Cap | Components | Weight |
| Large-Cap | 354,551,176,600 USD | 11 | 12.88% |
| Mid-Cap | 95,989,808,800 USD | 30 | 40.69% |
| Small-Cap | 28,626,985,840 USD | 36 | 44.96% |
| Micro-Cap | 380,697,720 USD | 2 | 1.46% |
| Total | 479,548,668,960 USD | 79 | 100.00% |
